# Heparin

## Hepac Plus for Dialysis 5000 Unit/20mL(250Unit/mL)

| 藥品代碼       | IHEP20                                                                                                                                                                                                                                                                                                                                                        |
|:---------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Anticoagulant for extracorporeal circulation device during hemodialysis.                                                                                                                                                                                                                                                                                      |
| 用法用量       | 1000-3000 units before general systemic heparinization， followed by 500-1500 units hourly after starting of dialysis， or adding on 500-1500 units intermittenly could be considerated.                                                                                                                                                                      |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                  |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                  |
| 禁忌           | Hypersensitivity to the drug， Bleeding disorders， Severe thrombocytopenia， Patients who can't undergo regular blood coagulation tests， Patients with heparin-Induced Thrombocytopenia.                                                                                                                                                                    |
| 副作用         | Common Hematologic: Thrombocytopenia (Up to 30% ) Hepatic: Increased liver aminotransferase level Serious Hematologic: Hemorrhage (5% to 10% )， Heparin-induced thrombocytopenia (0.6% to 10% )， Heparin-induced thrombocytopenia with thrombosis (Less than 1% ) Immunologic: Hypersensitivity reaction Neurologic: Non-traumatic spinal subdural hematoma |
| 孕期用藥建議   | Compatible                                                                                                                                                                                                                                                                                                                                                    |
| 哺乳期用藥建議 | Compatible 哺乳時可使用                                                                                                                                                                                                                                                                                                                                       |

## HEPAC inj 25KIU/5mL

#### 一般可用

| 藥品代碼       | IHEPA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:---------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Unstable angina; Venous thromboembolism; Peripheral arterial embolism， Prevention of re-occlusion of the coronary arteries following thrombolytic therapy ， Venous thromboembolism ，Prophylaxis of post-op venous thromboembolism， Prevention of mural thrombosis                                                                                                                                                                                                                                                                                                                                          |
| 用法用量       | IV: 10000 IU as first dose， followed by 5000-10000 IU every 4-6 hours. IV infusion: 20000-40000 IU/day， adding in 1000mL solvent. Deep SC: 10000 IU every 8 hours or 15000-20000 IU every 12 hours.                                                                                                                                                                                                                                                                                                                                                                                                          |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 禁忌           | Patients predisposed to active bleeding including thrombocytopenia， peptic ulcer disease， cerebrovascular disorders， haemorrhagic blood disorders， bacterial endocarditis， severe hypertension， oesophageal varices. Recent surgery at sites where haemorrhage would be an especial risk. Severe renal and hepatic impairment. Cerebral or subarachnoid haemorrhage， abdominal or thoracic bleeding into closed space， severe traumatic bleed， hepatic， renal， splenic or arterial injury， severe haemostatic defect， arterial thrombosis with heparin-associated thrombocytopenia. IM admin.     |
| 副作用         | Slight fever， headache， chills， nausea， vomiting， constipation， epistaxis， bruising， slight haematuria， skin necrosis (SC inj)， osteoporosis， alopecia. Hypersensitivity reactions include urticaria， conjunctivitis， rhinitis， asthma， angioedema and anaphylactic shock. Priapism. Potentially Fatal: Heparin-induced thrombocytopenia with or without thrombosis; bleeding Dermatologic: Erythema， Injection site ulcer， After deep subcutaneous injection Hematologic: Hematoma， Heparin-induced thrombocytopenia (up to 30% ) Neurologic: Pain (Mild) Other: Irritation symptom， Local |
| 孕期用藥建議   | nan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 哺乳期用藥建議 | Compatible 哺乳時可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

## Hepac inj 1KIU/0.2mL

#### 一般可用

| 藥品代碼       | IHEPA1                  |
|:---------------|:------------------------|
| 適應症         | nan                     |
| 用法用量       | nan                     |
| 肝功能異常     | 無需調整劑量            |
| 腎功能異常     | 無需調整劑量            |
| 禁忌           | nan                     |
| 副作用         | nan                     |
| 孕期用藥建議   | Compatible              |
| 哺乳期用藥建議 | Compatible 哺乳時可使用 |

## Hepac Lock Flush 1000 Unit/10mL

#### 一般可用

| 藥品代碼       | IHLF                                                                                                                                                                                     |
|:---------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Solution is intended for maintenance of patency of intravenous injection devices only. (central line use)                                                                                |
| 用法用量       | Adult dosing: Port-A flush only. Hepac Lock Flush Solution is intended for maintenance of patency of intravenous injection devices only and is not to be used for anticoagulant therapy. |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                             |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                             |
| 禁忌           | Hypersensitivity to the drug， Bleeding disorders， Severe thrombocytopenia， Patients who can't undergo regular blood coagulation tests                                                 |
| 副作用         | Hemorrhage， allergic reactions                                                                                                                                                          |
| 孕期用藥建議   | nan                                                                                                                                                                                      |
| 哺乳期用藥建議 | Compatible 哺乳時可使用                                                                                                                                                                  |

